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INTRODUCTION:  
With the increasing life span there are large numbers of 
patients above 65yrs of age. They present with multiple 
diseases like hypertension, Diabetes, Arthritis, Cancer 
cardiovascular diseases & neurological problems which 
warrant the consumption of more drugs compared to 
young adults.
1
This may lead to increased risk of errors. 
As age advances the drugs remain in the body for long 
periods because of delayed absorption and get 
concentrated in discrete parts of the body due to 
reduced cardiac output and poor circulation, decreased 
metabolism by shrunken liver and decreased renal 
function leading to decreased excretion of drugs. All 
these features lead to increase in the incidence of 
adverse drug reactions. Moreover use of more number 
of drugs may result in increased number of drug-drug 
interactions. In addition to using multiple prescribed 
medications older people are also major users of 
complementary and alternative medicines and may not 
report this without prompting. They are at great risk of 
adverse effects and herb-drug interactions because of 
using complementary and alternative medicines 
Objectives 
Goals of our study by reviewing various articles in 
literature are 
1. To assess the causes for polypharmacy 
2. To know the effects of polypharmacy 
3. To find out measures to reduce polypharmacy 
4. Management of polypharmacy 
METHODS 
Materials for this review were gathered from medline 
database. The search terms included were 
polypharmacy, multiple medications, elderly adults, 
geriatric. The articles were studied to know the various 
causes & effects of polypharmacy as mentioned in their 
studies. The various measures to reduce and manage 
polypharmacy were also noted. 
What is polypharmacy? 
Polypharmacy defined as the use of 5 or more 
medications occurs in 20 to 40% of older people
2
.  As 
per the WHO, Polypharmacy refers to use of multiple 
medications by a patient
3
 or more drugs are prescribed 
than clinically warranted or even when all prescribed 
medications are clinically indicated but are too many to 
take (pill burden). This has the potential to cause ADRS 
due to drug-drug interactions. The use of multiple 
medications is often referred to as polypharmacy
4
. A 
second and perhaps more important definition is the 
administration of more medications than are clinically 
indicated
5
. It is often defined as the use of four or more 
regular medications
6
.  
Causes for polypharmacy  
Elderly patients have many co morbidities requiring 
several medications for different problems. Research 
has made available a number of newer medications for 
use. Some of the patients are used to take OTC 
medications and herbal preparations without a clear 
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knowledge of their efficacy and adverse reactions. When 
side effects occur for some drugs they are misinterpreted 
as symptoms of a disease and additional/additive drugs are 
prescribed by the practitioner. Patients often visit several 
physicians without revealing the previous prescriptions and 
continue to take the medications prescribed by all the 
physicians without the knowledge of drug-drug 
interactions and overdosage
7
. 
Effects of polypharmacy in older adults 
Polypharmacy is associated with hospital admissions, 
functional and cognitive impairment, geriatric syndromes 
(Delirium, falls and Frailty) and mortality
8
. Polypharmacy 
is associated with an increased risk of falls in the elderly. 
Cardiovascular and psychoactive medications are well 
known to be associated with risk of falls. Every medication 
has potential adverse side effects and these seem to 
increase with the addition of new drugs.  
Elderly are more prone to drug-drug interactions due to 
various pharmacokinetic and pharmacodynamic 
variations
9
. The number of drug-drug interactions rises 
sharply when 5 or more medicines are taken concurrently. 
The findings of Kristina Johnell are that the probability of 
potentially serious DDIs decreases with increasing age 
among the elderly women than elderly men
10
. 
Risk of drug-disease interactions has been shown to 
increase with increased numbers of medications. With 
patients living longer with more chronic disease states 
requiring drug therapy, the risk of drug-disease interactions 
should be a concern for healthcare providers
11
.  
Polypharmacy and health care costs 
Polypharmacy contributes to health care costs to both the 
patient and the healthcare system. A retrospective cohort 
study found that polypharmacy was associated with 
increased medical expenditure due to risk of taking a 
potentially inappropriate medication with an increased risk 
of outpatient visits, and hospitalization(30% increase in 
medical costs)
12
. Another study conducted in Sweden 
reported that those taking 5 or more medications had a 
6.2% increase in prescription drug expenditure and those 
taking 10 or more medications had a 7.3% increase
13
. 
Polypharmacy and adverse drug reactions  
The harm associated with polypharmacy includes 
increased risk of adverse drug reactions which increases 
with the number of prescribed drugs. In a population based 
study, outpatients taking 5 or more medications had an 
88% increased risk of experiencing an ADE compared to 
those who were taking fewer medications
14
.  
Polypharmacy & Hospitalization 
Polypharmacy especially in elderly may lead to 
hospitalization due to various causes like adverse drug 
events, falls & functional decline. Unplanned 
hospitalization due to ADE’s was almost 4 times in elderly 
taking more than 5 medications than those taking less
15
. 
Functional and cognitive impairment in older people are 
strong predictors of hospital admissions
16
. The prevalence 
of falls strongly increases with age being more common in 
women than men. The risk of falling increased 
significantly with the number of drugs used per day
17
. In a 
prospective cohort study, the use of 4 or more medications 
was associated with increased risk of falling and the risk of 
recurrent falls
18
. A meta analysis showed an increased risk 
of falls in patients using diuretics, anti-arrhythmic drugs & 
psychotropics
19, 20
. 
Adherence to the medications is a common problem in the 
elderly if the number of drugs prescribed are more in 
number. Non-adherence with drugs in older adults has 
been associated with complicated medication regimens and 
polypharmacy. Medication non-adherence is associated 
with potential disease progression, treatment failure, 
hospitalization and ADEs, all of which could be life-
threatening
21
. 
Measures to reduce and manage polypharmacy 
Measures can be taken to limit polypharmacy to its truly 
legitimate and appropriate needs. Polypharmacy can be 
prevented by avoiding prescriptions for minor nonspecific 
or self limiting complaints. An accurate drug history is 
essential for patients on multiple drugs. This can be 
achieved by a regular medication review. (Several studies 
have proposed possible methods of reducing the number of 
medications for elderly patients). In prescribing to elderly 
patients the broad functional outcomes are usually the 
major therapeutic goal rather than the specific disease 
based outcomes. There are certain steps to be followed 
while prescribing in elderly patients 
 To determine the efficacy in the elderly 
 To determine the likely hood of adverse drug events 
in the older subjects 
 To discuss harm benefit analysis with the patient and 
then decide the dosage regimen considering the age 
related changes in the disposition of and response to 
medications
22
 
 Monitoring the patient very carefully is essential in 
view of the paucity of clinical trial data in frail older 
patients and the marked increase in prevalence of 
adverse drug reactions  
There are tools like Armor - A tool to evaluate 
polypharmacy in elderly patients
23
. ARMOR is a stepwise 
approach for assessment of a geriatric patient who is 
receiving nine or more medications; seen for initial 
assessment; seen for falls / behaviours; or admitted for 
rehabilitation. The clinician first observes heart rate, blood 
pressure (postural), and oxygen saturation rate at rest and 
with activity. A physician assessment and physical 
examination is followed by the following steps:  
A = Assess the individual for total number of medications 
and for certain group of medications that have potential for 
adverse outcome e.g. Beta blockers, Antidepressants, 
Antipsychotics, pain medications, vitamins and 
supplements 
R = Review for possible Drug-drug interactions, drug-
disease interactions. 
M = Minimize nonessential medication; eliminate 
medications that clearly lack evidence for their usage. 
Eliminate medications whose risks outweigh benefits and 
that have high potential for negative impact on primary 
functions. 
O = Optimize by addressing duplication, redundancy, 
adjust drugs according to the hepatic & renal functional 
status, adjust oral hypoglycaemics to blood sugar target  
HbA1C 
R = Reassess heart rate, blood pressure (postural), oxygen 
saturation at rest and activity. 
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DISCUSSION 
The use of multiple medications often termed 
polypharmacy is recognized as a potentially serious 
problem especially in the management of elderly patients. 
Polypharmacy can be negative or positive; the potential 
risks of polypharmacy are evident and need to be balanced 
with the benefits of use of multiple medications required to 
cure, slow the progression or reduce symptoms of disease. 
Several studies have shown the increased incidence of 
hospitalization due to falls as a result of functional 
disability, impaired cognition due to the usage of multiple 
medications. Several authors have reported an increase in 
the occurrence of adverse drug reactions when the number 
of medications is increased. Assessment of the need for 
polypharmacy and managing polypharmacy is important to 
meet the therapeutic goals of correcting functional, 
cognitive factors in addition to the morbidity & helps in 
better compliance in treating geriatric patients. 
 
 
CONCLUSION 
Polypharmacy is common and needed while treating 
elderly patients. Even though many studies proved the 
relationship between increased number of drugs and 
negative outcomes like adverse events, falls, 
hospitalization, more studies are needed to find out the 
measures for reducing polypharmacy  
Steps to reduce polypharmacy include better 
communication between the physician, nurse and 
pharmacist. Increasing the awareness of the physicians 
treating elderly on the occurrence of adverse events may 
help some extent. The elderly patients should also be made 
aware of the consequences of polypharmacy and 
convinced about revealing all the facts about the drugs 
they are already taking when they visit a physician. They 
should be discouraged to take unnecessary alternative 
medicines and OTC drugs. Even though polypharmacy is a 
double edged weapon the right use of it with better 
understanding of the outcomes is always beneficial to the 
elderly patients. Multidisciplinary teams, regular 
medication and reconciliation review can identify and 
reduce medication related problems. 
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